CS Genetics

Discovery Tools (Healthcare)

CS Genetics is a private discovery tools (healthcare) company. It has raised $16.9 million across 1 recorded round; the latest was a $16.9 million Series A in Sep 2022.

Last price · $/share
—
Implied valuation
—
Total raised
$16.9M
Last round
Later Stage VC (Series A)
Sep 2022
Valuation — not yet established

No valuation for CS Genetics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($16.9M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of CS Genetics with a free Private Market View account
  • ·Watch CS Genetics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CS Genetics funding history

1 rounds
DateRoundRaisedPost-money
Sep 2022Later Stage VC (Series A)$16.9M▮
Unlock post-money valuations

Membership and data by Private Market View

How much has CS Genetics raised?

CS Genetics has raised $16.9 million across 1 recorded round since 2022. The largest was a $16.9 million Series A in Sep 2022.

How CS Genetics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For CS Genetics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about CS Genetics

How much has CS Genetics raised?
CS Genetics has raised $16.9M in total funding across 1 recorded rounds.
When did CS Genetics last raise?
CS Genetics last raised in Sep 2022 (Later Stage VC (Series A)), raising $16.9M.